Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION: Buprenorphine, CBT, and TMS for Chronic Pain
NCT06442566Phase 2Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2024
- Primary completion
- Mar 2028
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of v1003 in chronic pain (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Buprenorphine Tolerability at Day 13 and Pain Severity - with Buprenorphine Patch at Day 20. Started Aug 2024; status: recruiting.
02
Drugs
v1003
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT06442566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06442566.